Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
666 | 3119 | 49.2 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1633 | 6468 | AMELOBLASTOMAS//HEDGEHOG//ODONTOGENIC KERATOCYST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEDGEHOG | Author keyword | 245 | 40% | 15% | 474 |
2 | SMOOTHENED | Author keyword | 186 | 72% | 5% | 147 |
3 | GLI | Author keyword | 168 | 64% | 5% | 163 |
4 | CYCLOPAMINE | Author keyword | 146 | 67% | 4% | 132 |
5 | PATCHED | Author keyword | 116 | 58% | 4% | 135 |
6 | SONIC HEDGEHOG | Author keyword | 112 | 30% | 10% | 315 |
7 | GLI1 | Author keyword | 110 | 61% | 4% | 117 |
8 | HEDGEHOG SIGNALING | Author keyword | 108 | 55% | 4% | 137 |
9 | HEDGEHOG SIGNALING PATHWAY | Author keyword | 89 | 74% | 2% | 67 |
10 | HEDGEHOG PATHWAY | Author keyword | 76 | 64% | 2% | 75 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEDGEHOG | 245 | 40% | 15% | 474 | Search HEDGEHOG | Search HEDGEHOG |
2 | SMOOTHENED | 186 | 72% | 5% | 147 | Search SMOOTHENED | Search SMOOTHENED |
3 | GLI | 168 | 64% | 5% | 163 | Search GLI | Search GLI |
4 | CYCLOPAMINE | 146 | 67% | 4% | 132 | Search CYCLOPAMINE | Search CYCLOPAMINE |
5 | PATCHED | 116 | 58% | 4% | 135 | Search PATCHED | Search PATCHED |
6 | SONIC HEDGEHOG | 112 | 30% | 10% | 315 | Search SONIC+HEDGEHOG | Search SONIC+HEDGEHOG |
7 | GLI1 | 110 | 61% | 4% | 117 | Search GLI1 | Search GLI1 |
8 | HEDGEHOG SIGNALING | 108 | 55% | 4% | 137 | Search HEDGEHOG+SIGNALING | Search HEDGEHOG+SIGNALING |
9 | HEDGEHOG SIGNALING PATHWAY | 89 | 74% | 2% | 67 | Search HEDGEHOG+SIGNALING+PATHWAY | Search HEDGEHOG+SIGNALING+PATHWAY |
10 | HEDGEHOG PATHWAY | 76 | 64% | 2% | 75 | Search HEDGEHOG+PATHWAY | Search HEDGEHOG+PATHWAY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SONIC HEDGEHOG | 279 | 21% | 39% | 1202 |
2 | CYCLOPAMINE | 197 | 73% | 5% | 149 |
3 | CUBITUS INTERRUPTUS | 172 | 52% | 8% | 236 |
4 | HEDGEHOG SIGNALING PATHWAY | 125 | 50% | 6% | 178 |
5 | CHOLESTEROL MODIFICATION | 95 | 68% | 3% | 83 |
6 | CUBITUS INTERRUPTUS PROTEIN | 81 | 60% | 3% | 87 |
7 | REPRESSOR FORMS | 79 | 91% | 1% | 32 |
8 | DROSOPHILA CUBITUS INTERRUPTUS | 65 | 93% | 1% | 25 |
9 | SMOOTHENED ACTIVITY | 65 | 95% | 1% | 21 |
10 | GLI | 62 | 62% | 2% | 63 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The mechanisms of Hedgehog signalling and its roles in development and disease | 2013 | 151 | 208 | 75% |
Unraveling the therapeutic potential of the Hedgehog pathway in cancer | 2013 | 74 | 110 | 78% |
Hedgehog Signaling in Development and Cancer | 2008 | 403 | 140 | 81% |
Mechanisms and functions of Hedgehog signalling across the metazoa | 2011 | 174 | 149 | 67% |
Gli Proteins in Development and Disease | 2011 | 129 | 166 | 76% |
Communicating with Hedgehogs | 2005 | 456 | 115 | 82% |
Hedgehog: functions and mechanisms | 2008 | 390 | 258 | 64% |
The Hedgehog's tale: developing strategies for targeting cancer | 2011 | 143 | 119 | 66% |
Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer | 2014 | 15 | 100 | 74% |
The Hedgehog Signal Transduction Network | 2012 | 63 | 226 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENET DEV EVOLUT | 7 | 67% | 0.2% | 6 |
2 | NEUROBIOL ALFRED FESSARD IFR2118 | 7 | 67% | 0.2% | 6 |
3 | DEV BIOL STEM CELL BIOL REGENERAT MED | 6 | 100% | 0.1% | 4 |
4 | DEV GENET PROGRAM | 5 | 15% | 1.0% | 31 |
5 | BRAIN TUMOR BIOL UNIT CIFA | 4 | 75% | 0.1% | 3 |
6 | CLIN HOSP PETROVA | 4 | 75% | 0.1% | 3 |
7 | INTERCELLULAR SIGNALLING GRP | 3 | 57% | 0.1% | 4 |
8 | SIGNAL TRANSDUCT DEV NEUROPHARMACOL TEAM | 3 | 50% | 0.1% | 4 |
9 | UNIDAD BIOL TUMO CEREBRALES | 3 | 50% | 0.1% | 4 |
10 | JIANGSU MOL TARGETED ANTITUMOR DRUG | 2 | 33% | 0.2% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000091930 | GAS7//GAS1//GROWTH ARREST SPECIFIC 1 |
2 | 0.0000084154 | ODONTOGENIC KERATOCYST//GORLIN SYNDROME//NEVOID BASAL CELL CARCINOMA SYNDROME |
3 | 0.0000064566 | LEG DEVELOPMENT//VESTIGIAL//HOMOTHORAX |
4 | 0.0000064400 | TNFAIP1//KCTD7//KCTD10 |
5 | 0.0000057574 | ISTHMIC ORGANIZER//GBX2//RHOMBOMERE 1 |
6 | 0.0000057326 | HOLOPROSENCEPHALY//OTOCEPHALY//HPE |
7 | 0.0000055438 | JOUBERT SYNDROME//BARDET BIEDL SYNDROME//INTRAFLAGELLAR TRANSPORT |
8 | 0.0000046266 | LIMB DEVELOPMENT//APICAL ECTODERMAL RIDGE//LIMB |
9 | 0.0000044960 | MEDULLOBLASTOMA//MEDULLOMYOBLASTOMA//CRANIOSPINAL IRRADIATION |
10 | 0.0000038655 | BICOID//GAP GENES//HUNCHBACK |